1. Home
  2. NOTV vs BHM Comparison

NOTV vs BHM Comparison

Compare NOTV & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • BHM
  • Stock Information
  • Founded
  • NOTV 1974
  • BHM 2022
  • Country
  • NOTV United States
  • BHM United States
  • Employees
  • NOTV N/A
  • BHM N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • BHM Real Estate Investment Trusts
  • Sector
  • NOTV Health Care
  • BHM Real Estate
  • Exchange
  • NOTV Nasdaq
  • BHM Nasdaq
  • Market Cap
  • NOTV 46.7M
  • BHM 51.9M
  • IPO Year
  • NOTV 1997
  • BHM N/A
  • Fundamental
  • Price
  • NOTV $1.39
  • BHM $11.42
  • Analyst Decision
  • NOTV Strong Buy
  • BHM Strong Buy
  • Analyst Count
  • NOTV 1
  • BHM 1
  • Target Price
  • NOTV $5.00
  • BHM $15.00
  • AVG Volume (30 Days)
  • NOTV 446.2K
  • BHM 3.3K
  • Earning Date
  • NOTV 08-06-2025
  • BHM 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • BHM 4.38%
  • EPS Growth
  • NOTV N/A
  • BHM N/A
  • EPS
  • NOTV N/A
  • BHM N/A
  • Revenue
  • NOTV $505,299,000.00
  • BHM $71,496,000.00
  • Revenue This Year
  • NOTV $5.64
  • BHM N/A
  • Revenue Next Year
  • NOTV $5.16
  • BHM N/A
  • P/E Ratio
  • NOTV N/A
  • BHM N/A
  • Revenue Growth
  • NOTV 0.85
  • BHM 27.87
  • 52 Week Low
  • NOTV $1.15
  • BHM $9.30
  • 52 Week High
  • NOTV $6.48
  • BHM $16.37
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 42.19
  • BHM 40.77
  • Support Level
  • NOTV $1.41
  • BHM $11.65
  • Resistance Level
  • NOTV $1.57
  • BHM $11.97
  • Average True Range (ATR)
  • NOTV 0.12
  • BHM 0.32
  • MACD
  • NOTV 0.02
  • BHM 0.05
  • Stochastic Oscillator
  • NOTV 31.19
  • BHM 59.41

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

Share on Social Networks: